Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Feb 04, 2024 10:08am
111 Views
Post# 35861808

RE:McMaster University studies have confirmed cannabinoid

RE:McMaster University studies have confirmed cannabinoid Nice find s1i   There is certainly a lot going on with regards to Medipharm and its clinical / academic partners and associates

With regards to Mr. Strachan's comment "FDA hurry up," I have looked back through the last couple months of his comments on X and couldnt find it, so there may be confussion in translation to what he actually said.

The confussion may have come from a post made by Solid1 on Jan 4, 2024:

RE:RE:Cannabis stocks gain amid report DEA reviewing legal status

Nice message from Keith Strachan on Twitter/X. It's so crystal clear... FDA move faster 


The closest I could find to any statement like that was a comment  made by Mr Strachan Jan 2, 2024 on X when he commented "

New year - new Dronabinol filling run! 99% purity & totally clear. This natural product will reach German patients later this months.


Solid1 would have to clarify if this was the comment he was refering to though ..........................
<< Previous
Bullboard Posts
Next >>